Hologic hits 52-week high on mammography study | Wall Street Beat

Shares of Hologic hit a 52-week high yesterday on a study showing the benefits of mammography using its Selenia 3D device.

Hologic [1] (NSDQ:HOLX [2]) shares hit a 52-week high yesterday on news that mammography using 3D technology significantly improved diagnostic accuracy.

HOLX shares reached their highest level since May 2011 yesterday, peaking at $23.22 apiece before closing at $22.36, up 7.0% on the day. Shares were trading at $22.39 as of about 12:50 p.m. today.

The Norwegian study, published in the journal Radiology [3], reviewed the results of 12,631 mammograms and found a 27% increase in detection rates for mammograms using 3D tomosynthesis technology. False-positive rates fell 15% and 25 additional invasive cancers were detected using the 3D technology, for a 40% boost.